Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.86 |
| ▸ | CES1 | P23141 | 2/20 | 0.86 |
| ▸ | CA1 | P00915 | 2/20 | 0.69 |
| ▸ | CA2 | P00918 | 2/20 | 0.69 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.50 |
| ▸ | SRC | P12931 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL223704 | 0.93 | CES1 (1.00) | CES2CES1CA1CA2BCHE | |
| SCHEMBL11588711 | 0.91 | CES1 (0.96) | CES2CES1CA1CA2BCHE | |
| Bromide SCHEMBL11420868 | 0.91 | CES1 (0.96) | CES2CES1CA1CA2BCHE | |
| SCHEMBL11588705 | 0.91 | CES1 (0.96) | CES2CES1CA1CA2BCHE | |
| Water SCHEMBL9045475 | 0.91 | CES1 (0.96) | CES2CES1CA1CA2BCHE | |
| P-Nitrophenylphosphate SCHEMBL2771528 | 0.90 | CA1 (0.86) | CES2CES1CA1CA2BCHE | |
| Pyrophosphoric Acid SCHEMBL29033361 | 0.86 | CES1 (0.86) | CES2CES1CA1CA2BCHE | |
| SCHEMBL5246741 | 0.86 | CES1 (0.86) | CES2CES1CA1CA2BCHE | |
| SCHEMBL10410659 | 0.86 | CA1 (0.63) | CES2CES1CA1CA2BCHE | |
| SCHEMBL959287 | 0.86 | CA1 (0.63) | CES2CES1CA1CA2BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118165034-A | Nucleotide compound, composition and application thereof | 深圳市塔吉瑞生物医药有限公司 | 2024-06-11 | — | — | CN | disclosed |
| US-20230338409-A1 | NUCLEOSIDE DRUGS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION AND THEIR USES | MIRACURE BIOTECHNOLOGY LTD (CN) | 2023-10-26 | — | — | US | disclosed |
| WO-2012006187-A2 | METHODS AND DEVICES FOR THE SELECTIVE DETECTION OF MICROORGANISMS | C3 JIAN, INC. (US) | 2012-01-12 | — | — | WO | disclosed |
| US-20120003661-A1 | METHODS AND DEVICES FOR THE SELECTIVE DETECTION OF MICROORGANISMS | C3 JIAN, INC. (US) | 2012-01-05 | — | — | US | disclosed |
| CN-101617014-A | Flame-retardant adhesive composition, flexible copper-clad laminate and coverlay film | SHOWA HIGHPOLYMER | 2009-12-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230338409-A1 | NUCLEOSIDE DRUGS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION AND THEIR USES | PNP, MTAP, TYMP | CES2 336/4885CES1 185/4885CA1 3738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.